by Jon Fleetwood,Jon Fleetwood:
Forces your body to flood bloodstream with antibody proteins that ticks consume during feeding.
Pfizer and Valneva haveadvancedtheir experimental Lyme disease vaccine, PF-07307405 (LB6V, formerly VLA15), using the same core biological mechanism that sparked autoimmune arthritis concerns, lawsuits, and the eventual withdrawal of the only previous Lyme vaccine, LYMErix.
The jab works by forcing the body to produce antibodies against a bacterial protein that resembles a protein found in your own joint tissue, meaning those antibodies may also recognize similar structures in your joints and trigger an immune response there.
TRUTH LIVES on athttps://sgtreport.tv/
That means a mechanism previously tied to immune responses against joint tissue—producing Lyme-like symptoms—is now being brought back and positioned for broad public rollout.
Moreover, current data tracks antibody levels in the bloodstream over months, but does not map where those antibodies distribute in human tissues or how repeated boosting affects immune activity over the long term.
The vaccine is built to force the body to produce large quantities of anti-OspA IgG antibodies that circulate in the bloodstream.
Those antibodies remain inactive until a tick begins feeding.
At that point, the process engages.
Source: SGT Report
